四环医药(00460.HK)曾飙42% 拟于市场回购不超过5亿元股份

阿斯达克财经
07 Oct 2024

四环医药(00460.HK) 公布,计划于12个月内在市场购回总额不超过5亿元股份,公司股价今日(7日)高开13.89%后升幅扩大,最高见1.02元或飙升42%。现报0.88元,弹22.22%,成交5,396.3万股,涉资4,950.4万元。
本港部分医药股亦有追捧,康龙化成(03759.HK) 现报22元,升12.13%,成交838.72万股,涉资1.83亿元。复星医药(02196.HK) 现报18.56元,升10.21%,成交636.8万股,涉资1.16亿元。石药(01093.HK) 现报6.94元,升1.91%。

中生(01177.HK) 偏软,微跌0.5%,报4.13元,成交1.22亿元。信达生物(01801.HK) 更跌5.5%,报48.35元,成交3.51亿元。翰林制药(03692.HK) 靠稳,报21.6元。(mn/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-10-04 16:25。)

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10